English Journal
- [Pharmacological and clinical profile of bixalomer (Kiklin(®) capsules): a new therapeutic agent for hyperphosphatemia].
- Taniguchi K, Kakuta H, Tomura Y, Kaku S, Uchida W.Sourcekeiichi.taniguchi@astellas.com
- Nihon yakurigaku zasshi. Folia pharmacologica Japonica.Nihon Yakurigaku Zasshi.2013 Jun;141(6):333-7.
- PMID 23749074
Related Links
- Summary Generic Name Information. Generic Name: bixalomer. Therapeutic Subcategory: Other therapeutic products. Evaluate - intelligence you can act on. Evaluate delivers market intelligence with standardized, transparent, integrated data ...
- Astellas Pharma Inc.: Submits Application for Marketing Approval of. Bixalomer ( ASP1585) for Treatment of Hyperphosphatemia, in Japan. Tokyo, March 14, 2011 - Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: .
Related Pictures
★リンクテーブル★
| リンク元 | 「ビキサロマー」 |
「ビキサロマー」
- 英
- bixalomer
- 商
- キックリン
- 関
- その他の循環器官用薬